SCIENCE . EVIDENCE BASE
Every claim we make has a source
you can check.
Healos™ is built on peer-reviewed cellular science, not wellness trends.
This page is your reference library — every protocol element, every ingredient,
every comparison is anchored to published research. We encourage you to read the papers.
4
4 peer-reviewed anchors
19
19 international certifications
NEJM · Cell
ll Metabolism · NEJM · Cell · AHA
cGMP
cGMP · PDR · FDA-registered
PEER - REVIEWED FOUNDATION
The Four Scientific Pillars Behind The 91-Day Protocol
Every core mechanism in the Healos™ system is anchored to published, peer-reviewed research from the highest-impact journals
in cardiovascular and cellular biology. Each pillar is tagged below with the condition pages it's most relevant to —
so if you arrived here from a specific LP, you can confirm relevance quickly rather than reading all four cold.
MITOCHONDRIAL SCIENCE · NMN
NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR
Yoshino, J., Baur, J. A., & Imai, S. I. (2018). Cell Metabolism, 27(3), 513–528.
Delineates the molecular mechanisms of NMN on myocardial mitochondrial respiration and vascular endothelial remodeling — the cellular science underlying Stage A of the Healos™ protocol.
RELEVANT TO :
Post-Cardiac
ACHD
RECURRENCE · INFLAMMATION · NEJM
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Ridker, P. M., et al. (2017). New England Journal of Medicine, 377(12), 1119–1131.
Proves that chronic vascular endothelial inflammation is the root driver behind high myocardial infarction and stroke recurrence rates under standard disease management — the scientific basis for Healos™ anti-inflammatory cellular protocol.
RELEVANT TO :
Post-Cardiac
Post-Stroke
Prevention
VASCULAR AGING · SIRT1 · CELL JOURNAL
Impairment of an Endothelial NAD+-SIRT1 Pathway Is a Reversible Cause of Vascular Aging
Das, A., et al. (2018). Cell, 173(1), 74–89.
Demonstrates that targeting the SIRT1 pathway reverses vascular epithelial senescence — establishing the core scientific foundation for cell-level integration in the Healos™ 91-day reset timeline.
RELEVANT TO :
Post-Cardiac
Post-Stroke
ACHD
Prevention
HEALTHCARE ECONOMICS · CANADA · USA
National Health Expenditure Trends / Heart Disease and Stroke Statistics
Canadian Institute for Health Information (CIHI, 2025) · American Heart Association (AHA, 2024).
Authoritative data capturing the catastrophic out-of-pocket burden and long-term care costs associated with post-event chronic management — establishing the economic case for the Healos™ preventive investment model.
RELEVANT TO :
Prevention
These references support the biological mechanisms addressed by the Healos™ protocol. They do not constitute clinical trials of the Healos™ product itself.
Healos™ does not claim to replicate or replace the findings of these studies.
Looking for condition-specific findings? Post-Cardiac, Post-Stroke, and ACHD each have 2–3 additional papers unique to that condition on their own page.
QUALITY & COMPLIANCE
19 International Certifications — No Synthetic Chemical Toxicity
Every Healos™ cellular nutrition product uses endogenous molecules and bio-identical compounds,
certified across 19 independent international standards.
These are complementary support products — NOT pharmaceutical drugs.
FDA Registered Facility
USA
Manufacturing facility registered and inspected under US Food & Drug Administration standards.
PDR Listed
USA · Clinical
Listed in the Physicians' Desk Reference — the standard US clinical pharmacopeia used by physicians.
cGMP Certified
International
Current Good Manufacturing Practice — the highest manufacturing quality standard for dietary supplements.
Summit Purity
Third Party
Independent third-party purity verification for heavy metals, contaminants, and potency accuracy.
Informed Sport /
NSF Certified
USA · Clinical
Rigorously screened for over 250 banned substances and toxic additives, ensuring maximum patient safety and formula transparency.
Halal Certified
International
Certified permissible under Islamic dietary law — suitable for Muslim patients worldwide.
Kosher Certified
International
Certified under Jewish dietary law (Kashrut) — rigorous purity and traceability standards.
+12 Additional Certs
19 Total
SQR, Organic, ISO 22000, non-GMO verification, allergen-free, and further international quality standards.
Complementary Support — Not Medical Treatment: Complementary support — not medical treatment. Always consult your cardiac or stroke specialist before starting any supplement programme. Individual results may vary. Healos™ cellular nutrition products are classified as dietary supplements, not pharmaceutical drugs. They are designed as complementary support to specialist-prescribed treatment. They are not intended to diagnose, treat, cure, or prevent any disease.
MODALITY COMPARISON
The 360° Comparative Blueprint
of Cardiovascular Recovery Approaches
How four recovery approaches compare across the dimensions that matter most to post-surgical patients.
Data drawn from clinical guidelines, published outcomes research, and standard-of-care documentation.
Competitor descriptions represent general category characteristics based on publicly available information and published clinical guidelines, not any single named provider or product. Individual provider offerings vary. Healos™ products are dietary supplements, not pharmaceutical drugs — they are not intended to diagnose, treat, cure, or prevent any disease, and are designed as complementary support alongside your prescribed medical care, never a replacement for it.
Always consult your physician, cardiologist, or pharmacist before starting any new supplement programme.
Insights · Blog
Cellular Science,
Made Readable
For post-surgical patients, caregivers, and clinicians who want to go deeper. New articles every two weeks.
NUTRITION SCIENCE
Why your statin is quietly depleting CoQ10
—and what that means for your heart？
Statins block the same pathway that produces CoQ10 — a molecule your mitochondria need to generate energy. Here's the mechanism, the risk, and the evidence-based response.
8 min read · Complementary to specialist care
RECURRENCE RISK
The 30–40% recurrence problem:
what the NEJM and AHA data actually say
One in three cardiac patients experiences a second event within five years. The data points to a single common driver that standard care systematically fails to address.
10 min read · Peer-reviewed sources
MIND - BODY
Fear of recurrence after cardiac surgery:
the invisible burden the system ignores
AHA 2024 research confirms: fear of having another heart attack persists for 6–8 months post-event — independent of anxiety and depression. Here's why that matters for recovery.
7 min read · AHA 2024 data
91-DAY SCIENCE
What actually happens to your vascular cells
in 91 days — a timeline
Vascular endothelial cells turn over on a 90-120 day cycle. The Healos™ 91-day protocol is timed to this biology. Here's what the research says about cellular renewal windows.
9 min read · Cell Metabolism · Das et al. 2018
Ready to see your own cellular data?
The H-Index™ audit is free, takes 15 minutes, and gives you your score instantly.
Healos™ Canada — Integrative cellular recovery for post-cardiac, post-stroke, and ACHD patients.
Ottawa.Toronto.Florida.New York.
SMS & voicemail: 365.909.2567
Ottawa, Ontario, Canada
PATIENT SERVICES
© 2026 Healos™ Canada · NoHeartAttack.com · Ottawa, Ontario Privacy - Terms - Refunds
Healos™ programmes are dietary supplements and integrative wellness services. They are not medical advice, not medical treatment, and not a substitute for professional medical care. Always consult your physician, cardiologist, or pharmacist before starting any new supplement programme. In case of cardiac emergency, call 911 immediately. Healos™ Canada